Show simple item record

Gene transefer as a new mode of vaccination: Implications for HCV

dc.contributor.authorGumucio, Jorge J.en_US
dc.contributor.authorMcDonnell, W. Michaelen_US
dc.date.accessioned2006-04-28T16:56:18Z
dc.date.available2006-04-28T16:56:18Z
dc.date.issued1993-09en_US
dc.identifier.citationGumucio, Jorge J.; McDonnell, W. Michael (1993)."Gene transefer as a new mode of vaccination: Implications for HCV." Hepatology 18(3): 696-698. <http://hdl.handle.net/2027.42/38400>en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/38400
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8395461&dopt=citationen_US
dc.description.abstractCytotoxic T lymphocytes (CTLs) specific for conserved viral antigens can respond to different strains of virus, in contrast to antibodies, which are generally strain-specific. The generation of such CTLs in vivo usually requires endogenous expression of the antigen, as occurs in the case of virus infection. To generate a viral antigen for presentation to the immune system without the limitations of direct peptide delivery or viral vectors, plasmid DNA encoding influenza A nucleoprotein was injected into the quadriceps of BALB/c mice. This resulted in the generation of nucleoproteinspecific CTLs and protection from a subsequent challenge with a heterologous strain of influenza A virus, as measured by decreased viral lung titers, inhibition of mass loss, and increased survival.en_US
dc.format.extent422580 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherW.B. Saundersen_US
dc.publisherWiley Periodiocals, Inc.en_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherHepatologyen_US
dc.titleGene transefer as a new mode of vaccination: Implications for HCVen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine Division of Gastroenterology (111D) VA Medical Center/University of Michigan Ann Arbor, Michigan 48105en_US
dc.contributor.affiliationumDepartment of Internal Medicine University of Michigan Medical School Ann Arbor, Michigan 48109–0362en_US
dc.identifier.pmid8395461en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/38400/1/1840180330_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/hep.1840180330en_US
dc.identifier.sourceHepatologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.